Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Biochem Pharmacol. 2021 Jul 23;193:114698. doi: 10.1016/j.bcp.2021.114698

Fig. 16.

Fig. 16.

Summary diagram of key findings of the study. PXR promotes hepatic steatosis and inflammation through gut microbiome in a male-specific manner. PXR worsens HFD-induced hepatic steatosis and inflammation accompanied by a PXR-dependent obesity- and inflammation-prone gut microbiome signature.